Form 8-K - Current report:
SEC Accession No. 0001493152-24-043821
Filing Date
2024-11-06
Accepted
2024-11-06 16:00:25
Documents
15
Period of Report
2024-10-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42594
2 ex16-1.htm EX-16.1 1040
3 ex16-1.jpg GRAPHIC 1706876
  Complete submission text file 0001493152-24-043821.txt   2564354

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcsa-20241031.xsd EX-101.SCH 3060
5 XBRL LABEL FILE pcsa-20241031_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pcsa-20241031_pre.xml EX-101.PRE 24195
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3786
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 241430747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)